Form 4: AdaptHealth CCO Executes Planned Stock Sale
Statement of Changes in Beneficial Ownership
AdaptHealth Corp. Chief Commercial Officer Russell E. Schuster III sold 11,275 shares of common stock via a Rule 10b5-1 plan.
Summary
- Russell E. Schuster III, Chief Commercial Officer of AdaptHealth Corp., sold 11,275 shares of common stock.
- The transaction occurred on June 1, 2026, at a price of $10.06 per share.
- Following the sale, the reporting person retains beneficial ownership of 136,538 shares.
- The sale was executed automatically under a Rule 10b5-1 trading plan adopted on March 2, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted under a pre-established 10b5-1 plan, which is a standard mechanism for executive stock divestment.
Positives
- The transaction was pre-planned under a Rule 10b5-1 trading plan, indicating the sale was not based on non-public information.
Negatives
- Insider selling can sometimes be perceived by the market as a lack of confidence in near-term share price appreciation.
Risks
- Continued reliance on Rule 10b5-1 plans for liquidity by key executives.
Future Outlook
No forward-looking guidance or operational outlook was provided in this filing.
Industry Context
StockSavvy.ai notes that routine insider selling via 10b5-1 plans is a standard practice for executives to manage personal liquidity and is generally viewed as neutral by the market unless the volume represents a significant portion of total holdings.
Comparison to Industry Standards
- The sale of 11,275 shares represents a small fraction of the executive's total holdings, consistent with standard executive diversification practices observed in the healthcare services sector.
Stakeholder Impact
- Minimal impact expected as the transaction was pre-planned and represents a small portion of the executive's total equity stake.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 02/04/2025 | Power of Attorney filed with the SEC. |
| 03/02/2026 | Adoption date of the Rule 10b5-1 trading plan. |
| 06/01/2026 | Date of the stock sale transaction. |
| 06/03/2026 | Date of filing. |
Keywords
AdaptHealth, AHCO, Insider Trading, Form 4, SEC Filing, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.